David R. Bailey

President and Chief Executive Officer at ORTHOPEDIATRICS

Board

Since June 1, 2021

Age

46 years

Education

Holds a Bachelor of Science in Sales and Sales Management from Purdue University and completed the Professional Leadership Development program at Harvard Business School in 2020.

Tenure

Joined KIDS in 2007 and held various leadership roles in sales, operations, and product development before being promoted to President and Chief Executive Officer on June 1, 2021, and appointed to the board on November 3, 2021.

Also at ORTHOPEDIATRICS

FLH

Fred L. Hite

Chief Financial Officer

DJG

Daniel J. Gerritzen

Executive Vice President (Legal), General Counsel, and Secretary

GAO

Gregory A. Odle

President of Scoliosis

About

David R. Bailey is a seasoned executive in the medical device industry, currently serving as the President and Chief Executive Officer of KIDS. Born around 1978, he is 46 years old as of 2025.

He holds a Bachelor of Science in Sales and Sales Management from Purdue University and furthered his professional development at Harvard Business School by completing the Professional Leadership Development program in 2020.

Starting his career at KIDS in 2007, he progressed through a series of leadership roles with responsibilities spanning domestic and international sales, operations, and product development. His contributions culminated in his appointment as CEO on June 1, 2021, and his subsequent appointment to the board of directors on November 3, 2021.

Throughout his career, his strategic initiatives have been instrumental in transforming the company from a start-up to a publicly traded enterprise, reflecting a commitment to leadership, innovation, and growth.

$KIDS Performance Under David R. Bailey

Past Roles

Organization	Role	Date Range	Details
OrthoPediatrics Corp. (KIDS)	Executive Vice President	2007 - June 3, 2020	Transitioned to President as part of the succession plan
OrthoPediatrics Corp. (KIDS)	Domestic & International Sales / Operations Oversight	2007 - June 3, 2020	Oversaw sales and operations functions
OrthoPediatrics Corp. (KIDS)	Trauma, Deformity Correction & Scoliosis Business Units Manager	2007 - June 3, 2020	Managed specific business units
Smith & Nephew Orthopaedics	Sales Representative & Independent Distributor	Prior to 2007	N/A

Fixed Compensation

Data from FY 2024

Component Name	Amount	Payment Schedule	Additional Details
Base Salary	$550,000	Annual	Fixed annual salary for 2024
Stock Awards	$2,693,771	As granted based on FASB ASC Topic 718	Aggregate grant date fair value of restricted share grants
All Other Compensation	$10,133	As incurred	Includes 401(k) matching contributions

Performance Compensation

Data from FY 2024

Sales Performance

Parameter	Value
Threshold	80% of the quarterly Sales Performance budget
Target	100% of the quarterly Sales Performance budget
Weight	40%
Conditions	No payout if below threshold; multiplier applied for overachievement
Evaluation Period	Quarterly

Adjusted EBITDA

Parameter	Value
Threshold	80% of the quarterly Adjusted EBITDA budget
Target	100% of the quarterly Adjusted EBITDA budget
Weight	25%
Conditions	No payout if below threshold; excess achievement annualized into a discretionary bonus pool
Evaluation Period	Quarterly

Individual Performance

Parameter	Value
Weight	10%
Conditions	Based on individual contributions and achievements

Corporate Objectives

Parameter	Value
Weight	25%
Conditions	Based on achievement of specific corporate goals

Bonus Summary

Parameter	Value
Base Salary (for bonus calc)	$550,000
Target Bonus Percentage	75%
Target Bonus Opportunity	$412,500
Actual Achievement	98%
Actual Bonus Award	$402,984
Grant Date	June 11, 2024
Vesting Schedule	Not applicable (cash bonus based on annual performance)